This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft, Compugen Ltd. Corporation. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2023
Title: The Innovations of Andrew Pow
Introduction
Andrew Pow is an accomplished inventor based in Burlington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on ILDR2 antagonists. His research and inventions have the potential to impact therapeutic treatments significantly.
Latest Patents
Andrew Pow holds 1 patent related to his work on ILDR2 antagonists and combinations thereof. This patent describes a novel pharmaceutical combination that includes an ILDR2 antagonist along with one or more other therapeutically active compounds. The invention aims to provide new therapeutic options for various medical conditions.
Career Highlights
Throughout his career, Andrew has worked with prominent companies in the pharmaceutical industry, including Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.
Collaborations
Andrew has collaborated with notable professionals in his field, including Lars Röse and Uwe Gritzan. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Andrew Pow's contributions to the field of pharmaceuticals through his innovative work on ILDR2 antagonists highlight his role as a significant inventor. His patent and collaborations reflect his commitment to advancing medical science and improving therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile